AMT-707

N/A

Report date: 2025/03/03 10:50:45

Base Information

Drug NameAMT-707
Drug Alias NameAMT-707CUSP-06
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Cadherin-6DNA topoisomerase I inhibitors
TargetsCadherin-6DNA topoisomerase I
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsCholangiocarcinoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMultitude Therapeutics Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesPuzhong Discovery Medical Technology (Shanghai) Co LtdOnCusp Therapeutics IncMultitude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsCholangiocarcinoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A